Although mitochondrial and serotonergic dysfunctions have been implicated in the etiology of bipolar disorder (BD), the relationship between these unrelated pathways has not been elucidated. A family of BD and chronic progressive external ophthalmoplegia (CPEO) caused by a mutation of the mitochondrial adenine nucleotide translocator 1 (ANT1, SLC25A4) implicated that ANT1 mutations confer a risk of BD. Here, we sequenced ANT1 in 324 probands of NIMH bipolar disorder pedigrees and identified two BD patients carrying heterozygous loss-of-function mutations. Behavioral analysis of brain specific Ant1 heterozygous conditional knockout (cKO) mice using lntelliCage showed a selective diminution in delay discounting. Delay discounting is the choice of smaller but immediate reward than larger but delayed reward and an index of impulsivity. Diminution of delay discounting suggests an increase in serotonergic activity. This finding was replicated by a 5-choice serial reaction time test. An anatomical screen showed accumulation of COX (cytochrome c oxidase) negative cells in dorsal raphe. Dorsal raphe neurons in the heterozygous cKO showed hyperexcitability, along with enhanced serotonin turnover in the nucleus accumbens and upregulation of Maob in dorsal raphe. These findings altogether suggest that mitochondrial dysfunction as the genetic risk of BD may cause vulnerability to BD by altering serotonergic neurotransmission.
Introduction
Bipolar disorder is a major mental disorder characterized by mania and depression. Dysregulation in both monoaminergic systems [1] and mitochondrial calcium signaling [2] have been proposed in the etiology of bipolar disorder. However, the relationship between these apparently unrelated metabolic signaling systems has not been elucidated [3] . Clinical studies showed that around 20% of patients with mitochondrial disease have comorbid bipolar disorder [4] [5] [6] , whereas 0.38% of patients with bipolar disorder had mutations of POLG (polymerase γ) causative for mitochondrial disease [7] . In a family of bipolar disorder and autosomal dominantly inherited chronic external ophthalmoplegia (CPEO), the L98P mutation of ANT1 (adenine nucleotide translocator 1, SLC25A4) was identified [8, 9] . These findings suggest that central nervous system involvement in mitochondrial disease caused by ANT1 mutations confers a risk of bipolar disorder. ANT1 is named for its function as a translocator of adenosine triphosphate and adenosine diphosphate across the mitochondrial inner membrane. However, its modulatory role in the mitochondrial permeability transition pore (mPTP) has also drawn attention [10] [11] [12] . The mPTP plays a role in regulated cell death, and transient opening of the mPTP also regulates mitochondrial calcium signaling [13] , which is consistent with the well-known calcium dysregulation hypothesis of bipolar disorder [14] .
In this study, we searched for ANT1 mutations in patients with bipolar disorder, and identified two independent loss of function (LOF) mutations of ANT1. We investigated the relationship between heterozygous loss of function of ANT1 and bipolar disorder by generating a brain specific Ant1 conditional knockout (cKO) mouse. By behavioral screening, we identified that the heterozygous mice showed diminished delay discounting, that is the choice of smaller but immediate reward than larger but delayed reward and an index of impulsivity [15] . Consistent with this finding, the mice had enhanced serotoninergic activity. These findings together shed new light on the mechanism of how ANT1 mutations may confer a risk for BD.
Materials and methods
The study was approved by the Wako first ethics committee of RIKEN. All animal care and experimental procedure were in accordance with the guidelines for proper conduct of animal experiments published by Science Council of Japan and approved by RIKEN Wako Animal Experiment Committee. Methods and materials are described in detail in Supplemental Experimental Procedures.
Subjects
All four exons of the SLC25A4 gene were sequenced by PCR-direct sequencing in 324 probands of NIMH Genetics Initiative bipolar disorder pedigrees. Their diagnosis was bipolar I (n = 304), bipolar II disorder (n = 17), or schizoaffective disorder, bipolar type (n = 3). 
Animals

Staining
Staining methods and antibodies are described in detail in Supplementary Methods. Fluorescent in situ hybridization was conducted as previously described [17] . Images were captured by a confocal microscope IX81 with FV1000 (Olympus Corporation, Tokyo, Japan), Observer Z1 with AxioVision 4.6 (Zeiss, Oberkochen, Germaney) or Nano Zoomer Digital Pathology system (Nanozoomer 2.0RS, Hamamatsu Photonics, Hamamatsu, Japan).
Mouse behavioral screening with IntelliCage
The IntelliCage apparatuses (NewBehavior AG, Zurich, Switzerland) were used for behavioral screening as described previously [18, 19] . Male mice including 8 heterozygous cKO mice (Slc25a4 fl/+ ; Nes-Cre+), 10 homozygous cKO mice (Slc25a4 fl/fl ; Nes-Cre+) and 6 controls (Slc25a4 fl/+ or Slc25a4 fl/fl ; Nes-Cre−), which were 20-27 week old, were used.
5-choice serial reaction time task (5-CSRTT)
The 5-CSRTT operant chamber (O'HARA & Co., Tokyo, Japan) was used as previously described with minor modification [20] . ; Nes-Cre+), which were 8-13 week old at the beginning of training, were used for the analysis.
Quantification of mtDNA deletion and mtDNA copy number
Partially deleted mitochondrial DNA (ΔmtDNA) and copy number of mtDNA was measured by quantitative PCR methods using SYBR Premix Ex Taq Kit (Takara Bio, Otsu, Japan) and QuantStudio 12 K Flex (Thermo Fisher Scientific, Waltham, MA) as described [21] . For quantification of mtDNA deletion 30-39 week old male mice were used. For mtDNA copy number analysis, 54-56 week old male mice were used. Control mice were Slc25a4 fl/+ or Slc25a4 fl/fl without Nestin-Cre.
Quantification of Ant1/Ant2 mRNAs mRNA expression of Ant1 (Slc25a4) and Ant2 (Slc25a5) were measured by quantitative PCR methods using SYBR Premix Ex Taq Kit (Takara Bio, Kusatsu, Japan) and QuantStudio 12 K Flex (Thermo Fisher Scientific, Waltham, MA). For these analysis, female 78-114 week old mice were used (n = 3 for each group). 
Measurement of calcium retention capacity
Brain mitochondria were isolated using a discontinuous Percoll gradient developed by Sims [22] with minor modifications [23] . Extra-mitochondrial free Ca ; Nes-Cre−) (n = 3) aged 8-27 weeks were used for this analysis.
Quantification of monoamine in tissue by HPLC
Dopamine, noradrenaline and serotonin and their metabolites were measured by HPLC with an EICOMPAK SC-5ODS with electrochemical detector ECD-300 (Eicom Corporation, Kyoto, Japan). In this experiment, control mice included Slc25a4 +/+ ; Nestin-Cre+ and
For this experiment, 88-103 week old male mice were used.
Electrophysiological analysis
Brain slices for experiments were prepared from 10-12-week-old, male mice as described previously [24] . Whole cell patch-clamp recordings were acquired and controlled using the Axon 700B Multiclamp amplifer (Molecular Devices, CA, US) and pClamp11 acquisition software (Molecular Devices, CA, US). For this analysis, heterozygous Ant1 cKO mice (Slc25a4 fl/+ ; Nes-Cre+) (n = 4) and control mice (Slc25a4 fl/+ without Nes-Cre) (n = 3) aged 8-12 week old were used.
Statistical analysis
Data were analyzed by Prism 4 (Graphpad softoware Inc., San Diego, CA), IBM SPSS Statistics 20 (IBM Japan, Tokyo, Japan), "R" (https://www.r-project.org/) or Kyplot (Kyence, Tokyo, Japan). For genetic association analysis, Fisher's exact probability test was used. In the comparison between the heterozygous or homozygous cKO mice and control mice, Student t-test was used. For place learning task and delay discounting task in IntelliCage, repeated measures ANOVA with Bonferroni's post hoc test was used with main effects of genotype and delay or day.
Results
Identification of loss of function mutations in bipolar patients
We sequenced the ANT1 gene in 324 NIMH probands with bipolar disorder and identified two patients carrying LOF mutations. One patient had a stop codon mutation p.Q85X, a substitution of C to T at Figures 1A-B) , which was reported in a pedigree of recessive cardiomyopathy with comorbid depression and anxiety [25] . The frequency of LOF mutations (gain of stop codon or frame shift) for ANT1 in BD (2/324, 0.61%) was significantly higher than that in the exome and genome data in the gnomAD database (10 of 128,632 [2 stop codons and 8 frameshift mutations], 0.000069%, Fisher's exact probability test, P = 0.00040, odds ratio = 79.7 [95%CI: 8.4-374.4]). Both mutations were on exon 3 and were thus predicted to undergo nonsense-mediated mRNA decay. Even when cDNAs of the predicted mutant mRNA encoding truncated proteins were constructed, protein expression of these mutants was markedly reduced in Neuro 2A cells ( Supplementary Figure 1C) . Although the two mutations did not show complete cosegregation with BD in the two pedigrees partly because of bilinear transmission ( Supplementary Figure 1D) , the significant association with high odds ratio suggested the role of these LOF mutations as a genetic risk factor for BD.
Generation of brain-specific Ant1 cKO mice ANT1 mutations are known to cause a neuromuscular disorder, CPEO, and thus behavioral analyses must be performed using brain-specific mutant mice. We crossed floxed Ant1 mice (Slc25a4 fl/fl or Slc25a4 fl/+ ) with Nestin-Cre transgenic mice to generate a brain-specific cKO Ant1 mouse (Fig. 1a) . We verified that the homozygous Ant1 cKO mice (Slc25a4 fl/fl ; Nestin-Cre+) have no Ant1 mRNA (Fig. 1b) and protein ( Fig. 1c) without Nestin-Cre). No compensatory upregulation of Ant2 mRNA was observed (Fig. 1e) .
To examine the functional consequences of the loss of ANT1, we isolated mitochondria from Ant1 cKO mice. The mitochondrial calcium retention capacity was significantly lower in homozygous Ant1 cKO mice (P = 0.02) (Figs. 1f, g ) suggesting that the mitochondria of homozygous Ant1 cKO mice are vulnerable to the mPTP opening. The calcium retention capacity of heterozygous Ant1 cKO mice did not significantly differ from controls.
Because the identified patients with bipolar disorder were heterozygous for LOF mutations in ANT1, we performed the murine behavioral characterization in heterozygous Ant1 cKO mice to model the human disorder. Homozygous cKO mice were examined as a reference control, and Slc25a4 fl/+ or Slc25a4 fl/fl without Nestin-Cre, or Slc25a4 +/+ ; NestinCre+ were also examined as controls.
Behavioral phenotypes of brain-specific Ant1 cKO mice
We performed behavioral screening using the IntelliCage (Fig. 2a) . Indices for spatial learning, reverse learning, and attention did not differ between genotypes (Supplementary Figures 2A-E) , but the heterozygous cKO mice showed a significantly decreased delay discounting (Fig. 2b) . The preference for saccharin did not differ between genotypes (F = 1.0, P = 0.36 by one way ANOVA) (Supplementary Figure 2F) , suggesting that this finding is not due to altered reward value. Homozygous Ant1 cKO mice also showed a similar behavioral phenotype (Fig. 2b) , although more similar to controls than heterozygous cKO mice.
To further characterize the behavioral phenotypes of heterozygous Ant1 cKO mice, we performed a 5-choice serial reaction time test (5-CSRTT), an established test to measure impulsivity [26] as a reflection of enhanced delay discounting (Figs. 2c-f, Supplementary Figures 2G-I) . In this test, the number of premature nose pokes during long stimulus duration trials, which is an index of impulsivity, was significantly lower in heterozygous cKO mice than control mice (Fig. 2d) . A decrease of impulsivity is equivalent to a decrease in delay discounting shown by the IntelliCage (Fig. 2b) . The heterozygous cKO mice also showed better accuracy (Fig. 2e) and a lower number of perseverative responses than control mice in the long intertrial interval trials (Fig. 2f) . Homozygous cKO mice did not show similar phenotypes in the 5-CSRTT for unknown reasons.
Anatomical screen
We searched for brain regions with mitochondrial dysfunction due to the heterozygous knockout of Ant1 by performing COX (cytochrome c oxidase)/SDH (succinate dehydrogenase) co-staining. COX is a mtDNA-encoded protein whereas SDH is a nuclear-encoded mitochondrial protein, and COX-negative cells were detected in a model mouse of mitochondrial disease [27] . In a sagittal section of aged homozygous Ant1 cKO mice, COX negative cells were detected preferentially in the dorsal raphe (DR) (Fig. 3a) and heterozygous Ant1 cKO mice also showed COX negative cells in the DR (Fig. 3b) . Unexpectedly, however, a similar accumulation of COX negative cells was also detected in the DR of wild type mice (Fig. 3b) . In this region, mtDNA deletions (ΔmtDNA) were not detectable both in cKO and control mice (Fig. 3c) . Thus, the DR may have a selective vulnerability to mitochondrial dysfunction unrelated to the accumulation of ΔmtDNA, and the phenotype of the mutant mice might be caused by an interaction of the genotype and a general vulnerability of DR neurons to mitochondrial dysfunction. The copy number of mtDNA was significantly increased in DR of heterozygous cKO mice compared with control mice (Fig. 3d) .
Serotonergic dysfunction in Ant1 KO mice
The activation of serotonergic neurons reportedly attenuates delay discounting [28] , and therefore we examined serotonin turnover in the nucleus accumbens, which is innervated by DR serotonergic neurons and regulates impulsivity [29] . We found that serotonin turnover was enhanced in the nucleus accumbens of heterozygous KO mice (Fig. 3e) . There was no significant difference of the serotonin turnover between NestinCre and wild type mice (0.55 ± 0.07 vs 0.75 ± 0.17, respectively, P = 0.15, n = 3 for both groups). We also analyzed the gene expression level of Maob (monoamine oxidase B) that encodes a monoamine metabolizing enzyme on the mitochondrial outer membrane enriched in the DR [30] . To normalize expression levels of Maob by the number of serotonergic neurons within the sample, a serotonin neuron specific gene, Tph2 or Slc6a4, was used for a reference. We found that Maob mRNA was significantly increased in the DR Fig. 2 Behavioral analysis of Ant1 cKO mice by IntelliCage and fivechoice serial reaction time test (5-CSRTT). a Schematic drawing of delay discounting task in IntelliCage. The actions such as nose poking and licking of mice in each corner to drink running water (cyan) or 0.5% saccharin containing water (green) can be automatically recorded. b Percentages of nose poke counts for saccharin water in total nose poke counts in each day without or with activation delay after corner entry. Nose poke ratios for saccharin water of heterozygous (n = 8, red) and homozygous (n = 10, blue) conditional knockout mice were higher than control mice (n = 6, black) in long delay (≥3 s). Each circle represents mean and error bars indicate standard error of mean (SEM). **P < 0.005; *P < 0.05 (Bonferroni's post hoc test after twoway repeated measures ANOVA). Red and blue asterisks indicate the comparisons of control vs heterozygous cKO, or control vs homozygous cKO, respectively. c Schematic drawing of 5-CSRTT. A sugar pellet was delivered to food magazine by a correct nose poke at an illuminated hole among five holes during limited hold. LED which was a sign for a correct hole was turned on after inter trial interval (ITI) for the defined period in each test. Premature or mistake nose poke and omission trial will lead to additional punishment delay in which room light was shut down for 5 s. d Number of premature nose poke in heterozygous mutant mice was significantly decreased compared with that in control mice in long stimulus duration test. e Accuracy (percentage of correct nose poke / (correct nose poke + mistake)) was significantly higher in heterozygous Ant1 cKO mice compared with controls in long-ITI test. f Number of preservative responses was lower in heterozygous Ant1 cKO mice compared with controls in long-ITI test. **P < 0.005; *P < 0.05, + P = 0.05. SD stimulus duration, ITI inter-trial interval, NP nose poke of heterozygous Ant1 cKO mice (P < 0.05) (Figs. 3f, g ) consistent with the elevated turnover of serotonin in the nucleus accumbens.
To test whether serotonergic neurons were activated in the Ant1 cKO mice, we performed electrophysiological recordings from midbrain slices containing the DR. As shown in Supplementary Table 1, both basic membrane properties and action potential properties of serotonergic neurons at the midline of the DR did not show significant differences between genotypes. However, the input-output relationship curves, which show the generation of action potentials by current injection was steeper in heterozygous Ant1 cKO mice than that of controls (Fig. 4) indicating that serotonergic neurons of heterozygous Ant1 cKO mice are more excitable.
Discussion
In this study, we identified two patients with bipolar disorder carrying loss of function mutations in ANT1 (Supplementary Figure 1 ). Brain-specific heterozygous cKO mice of Ant1 showed diminished delay discounting or reduced impulsivity by two behavioral tests (Fig. 2) . Enhanced serotonin turnover (Fig. 3e) and hyperactivity of serotonergic neurons (Fig. 4) were consistent with the behavioral phenotype [28] . Increased mtDNA copy number in DR (Fig. 3d) might reflect an increased energy demand in the DR, and upregulation of Maob mRNA is considered a compensatory upregulation associated with enhanced serotonergic activity. These findings, together, suggest that the heterozygous loss of Ant1 in the brain causes a hyperserotonergic state and associated behavioral phenotypes.
The mechanism of how the heterozygous loss of function of Ant1 causes serotonergic hyperactivity is not known. Elevated intracellular calcium associated with depolarization is sequestered by mitochondria. The accumulation of intramitochondrial calcium results in a transient opening of the mPTP [31] . Ant1 reportedly has a modulatory effect on the mitochondrial permeability transition pore (mPTP) [10] . An altered mPTP function associated with heterozygous loss of Ant1 might affect the excitability of DR neurons. A previous study reported exaggerated corticosterone responses to stress in homozygous conventional Ant1 KO mice [32] . Enhanced serotonergic function might also underlie this finding, because serotoninergic stimulation is known to activate the hypothalamic-pituitary-adrenal axis [33] .
Why are serotonergic neurons preferentially affected by the heterozygous loss of Ant1? Monoamines are metabolized by monoamine oxidases (MAOs) on the mitochondrial outer membrane. Metabolism of monoamines by MAOs is accompanied by the generation of hydrogen peroxide, a reactive oxygen species [30] . Enhanced serotonin release by 3,4-methylenedioxymethamphetamine (MDMA) can decrease COX protein levels, which can be rescued by an MAO-B inhibitor [34] . Images were obtained by confocal microscopy (FV1000). c Quantification of mtDNA deletions (ΔmtDNAs) by quantitative PCR. The bar indicates average. There was no significant difference of ΔmtDNAs between heterozygous Ant1 cKO mice (n = 8) and control mice (n = 8). The homozygous cKO mice (n = 10) also did not accumulate mtDNA deletions. d Quantification of mtDNA copy number. A nuclear gene RNaseP was used as a reference. Heterozygous Ant1 cKO mice (n = 3) had significantly higher levels of mtDNA than control mice (n = 3) (P < 0.01). The homozygous cKO mice (n = 3) also showed a tendency of elevation of mtDNA levels (P = 0.07). e The 5HIAA (5-hydroxyindole acetic acid)/5-HT (5-hydroxytryptamine, serotonin) ratio indicating turnover of serotonin is accelerated in heterozygous Ant1 cKO mice compared with control mice. **P < 0.005. Homozygous Ant1 cKO did not significantly differ from controls (P = 0.42). f, g Maob mRNA levels in dorsal raphe of Ant1 KO mice. Heterozygous Ant1 cKO mice showed significantly increased Maob/ Tph2 (f) and Maob/Slc6a4 (g) ratios compared with control mice We speculate that serotonergic neurons may be intrinsically vulnerable to mitochondrial dysfunction, and the hyperserotonergic state may further impair mitochondrial function in a vicious cycle. The results of the COX/SDH staining in this study support this hypothesis. The degeneration of DR serotonergic neurons is frequently seen in Parkinson's disease, in which mitochondrial dysfunction is implicated, and this might at least partly explain the non-motor symptoms of this disease [35] . In Parkinson's disease, 8-hydroxyguanosine is accumulated in substantia nigra dopaminergic neurons, and this is also true for the DR [36] . Thus, the mitochondrial dysfunction phenotype due to the heterozygous cKO of Ant1 is predominantly seen in serotonergic neurons, which may have an intrinsic vulnerability to mitochondrial dysfunction. The mechanism of how COX immunoreactivity is reduced in the DR is not known because the present study did not show an increase of ΔmtDNA levels or a decrease of mtDNA copy number. Reduction of COX immunoreactivity in DR neurons might be regulated by other types of mtDNA abnormalities and/or at the protein level [37] . Mitochondrial dysfunction has been implicated in bipolar disorder based on several lines of evidence [2] including altered energy metabolism detected by magnetic resonance spectroscopy [38] , comorbidity with mitochondrial diseases [4, 7] , and findings in postmortem brains including an accumulation of ΔmtDNAs [39, 40] , altered gene expression of mitochondria-related genes [41] , altered morphology of mitochondria [42] , and decreased activity of mitochondrial complex I [43] . On the other hand, serotonergic dysfunction in bipolar disorder has been implicated by evidence including the maniainducing effect of antidepressants that inhibits the serotonin transporter and thereby activates serotonin [44] , the efficacy of atypical antipsychotics that inhibits serotonergic neurotransmission [45] , altered mRNA expression levels of serotonergic receptors in postmortem brain [46] , altered DNA methylation of serotonin transporter gene [47] , altered serotonin transporter binding in the brain by positron emission tomography [48] , and levels of cerebrospinal fluid metabolites, among others [14] . The present findings provide a potential missing link between these two lines of evidence. Because the two LOF mutations identified in this study were not cosegregated with bipolar disorder in the two pedigrees, they are not "causative" mutations. However, their significant association suggests that the heterozygous LOF mutations of ANT1 confer the risk of bipolar disorder.
There are several limitations in this study. Notably, it is unknown why homozygous Ant1 cKO mice do not show behavioral alterations in some experiments. However, such non-linear dynamics are inherent to complex biological systems such as the brain. Secondly, Nestin-Cre mice reportedly have some behavioral alterations [49] , which could in principle confound the results. However, we verified that this transgene did not affect serotonin turnover and excitability of DR serotonergic neurons (Supplementary Figure 3) . Thirdly, behavioral analysis is confounded by genetic background [50] . Although all the mice used were generated and/or kept under the background of C57BL/6, there are subtle behavioral differences even among C57BL/ 6 substrains [51] . We therefore used the mice after backcrossing with C57BL/6J, though the number of generations might not be enough to rule out a possible effect of substrains. Finally, the results in calcium retention capacity are not consistent with previous studies that showed a loss of Ant1 causing an increase in calcium retention capacity [52] . This discrepancy might be due to differences in experimental conditions or mouse strains.
In summary, our current findings suggest that mitochondrial dysfunction caused by heterozygous loss of Ant1 can cause alterations of serotonergic activity, a first step toward understanding the complex neurobiological processes underlying bipolar disorder subtypes.
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